The European Network of Pediatric Research at the European Medicines Agency will hold its ninth annual workshop on 16 May 2017 in London, UK. The main objective of the workshop is to bring important stakeholders together to discuss necessities, hurdles and prospects for high-quality clinical studies in children.
Among the highlights of this year’s workshop are the current struggles to maximize collaboration between the European Union and the United States to facilitate global pediatric trials and medicine developments.
The first day of the workshop will be open to all stakeholders comprising:
- Patients/parents
- Organizations,
- Regulators
- Enpr-EMA network representatives
- Academia
- Clinical investigators and representatives from the pharmaceutical industry for pediatric studies.
Participants will hear about Enpr-EMA’s activities to substitute high-quality research in pediatric medicine and will be invited to share their views on the successes made so far and the way forward.
Registration for the first day of the workshop is open until 28 April 2017.
The second day of the workshop is kept for discussions among the members of Enpr-EMA and the Enpr-EMA organizing group. The organizing group will define significances for 2017-2018 based on the feedback received from stakeholders.
Enpr-EMA was set up to help the conduct of clinical studies in children. It is an umbrella network of 39 national and international networks known for their experience in pediatric research. It acts as a platform for sharing good practices.
Dated :9TH Feb 2017